SearchDictionaryMobileLogin

Catheter-Related Infections

Subscribe to Selected New Research on Catheter-Related Infections
358  relevant articles (33 outcomes, 37 trials/studies) found for this Disease

Description: Infections resulting from the use of catheters. Proper aseptic technique, site of catheter placement, material composition, and virulence of the organism are all factors that can influence possible infection.

Also Known As:
Catheter Related Infections; Catheter-Related Infection; Infection, Catheter-Related; Infections, Catheter-Related

Relationship Network

Disease Context: Research Results

-
Bacterial Infections and Mycoses
-
Infection: 225242
*
Catheter-Related Infections: 358

Related Diseases

1. Infection
2. Melanoma (Melanoma, Malignant)
3. Sepsis (Septicemia)
4. Fever (Fevers)
5. Acute Kidney Failure (Acute Renal Failure)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Catheter-Related Infections:
1. Rifampin (Rifampicin)FDA LinkGeneric
2. Anti-Bacterial Agents (Antibiotics)IBA
3. Heparin (Liquaemin)FDA LinkGeneric
4. SilverIBA
5. Minocycline (Cyclops)FDA LinkGeneric
6. ChlorhexidineIBA
7. Silver Sulfadiazine (SSD)FDA LinkGeneric
8. VancomycinFDA LinkGeneric
9. Mupirocin (Bactroban)FDA LinkGeneric
10. Gentamicins (Gentamicin)FDA LinkGeneric

Therapies and Procedures

1. Renal Dialysis (Hemodialysis)
2. Drug Therapy (Chemotherapy)
3. Peritoneal Dialysis
4. Intensive Care (Surgical Intensive Care)
5. Antibiotic Prophylaxis
01/01/2001 - "Role of antibiotic prophylaxis for the prevention of intravascular catheter-related infection."
01/01/1998 - "CONCLUSION: Intraperitoneal antibiotic prophylaxis for 3 weeks after catheter implantation is an effective way to prevent early colonization of exit sites, providing a better healing quality and lower incidence of catheter-related infection. "
10/01/1990 - "Antibiotic prophylaxis to prevent catheter-related infections in recombinant interleukin-2-treated patients."
03/01/2009 - "Vancomycin flush as antibiotic prophylaxis for early catheter-related infections: a cost-effectiveness analysis."
01/01/2001 - "Appropriate use of prophylaxis to prevent venous thromboembolism in patients at risk; Use of perioperative beta-blockers in appropriate patients to prevent perioperative morbidity and mortality; Use of maximum sterile barriers while placing central intravenous catheters to prevent infections; Appropriate use of antibiotic prophylaxis in surgical patients to prevent postoperative infections; Asking that patients recall and restate what they have been told during the informed consent process; Continuous aspiration of subglottic secretions (CASS) to prevent ventilator-associated pneumonia; Use of pressure relieving bedding materials to prevent pressure ulcers; Use of real-time ultrasound guidance during central line insertion to prevent complications; Patient self-management for warfarin (Coumadin) to achieve appropriate outpatient anticoagulation and prevent complications; Appropriate provision of nutrition, with a particular emphasis on early enteral nutrition in critically ill and surgical patients; and Use of antibiotic-impregnated central venous catheters to prevent catheter-related infections. "
Order ALL the reference details at left...

Best Treatments:
Research Summary Report
on Catheter-Related Infections
*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 33 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>